Campylobacter upsaliensis exerts a cytolethal distending toxin effect on HeLa cells and T lymphocytes.

Campylobacter upsaliensis is an emerging human enteropathogen. However, little is known about the pathogenesis of C. upsaliensis infection. In this study the authors demonstrate that C. upsaliensis whole-cell preparations and extracts produce a cytolethal distending toxin (CDT)-like effect on HeLa cells characterized by progressive distension and nuclear fragmentation culminating in cell death over 5 d. To further delineate the nature of this toxic effect in relation to CDT from other pathogens, the effect of C. upsaliensis on cellular events in epithelial cells and immunocytes was investigated. C. upsaliensis lysate-treated HeLa cells subjected to FACScan analysis using carboxyfluorescein diacetete succinimidyl ester (CFDA-SE) as a cell tracer demonstrated cell division arrest. Propidium iodide (PI) staining of HeLa cells revealed that cell cycle arrest occurred in G(2)/M. Human T lymphocytes exposed to C. upsaliensis lysates also showed cell cycle arrest in G(2)/M. Using a combination of Annexin V/PI staining and TUNEL assay, cytodistended HeLa cells were shown to undergo apoptotic cell death. These data provide the first insights into the virulence mechanisms of this novel enteropathogen.

[1]  C. Buswell,et al.  Characterisation of cytolethal distending toxin (CDT) mutants of Campylobacter jejuni. , 2000, Journal of medical microbiology.

[2]  C. Tasca,et al.  Sequence of lethal events in HeLa cells exposed to the G2 blocking cytolethal distending toxin. , 2000, European journal of cell biology.

[3]  E. Hansen,et al.  Cytolethal Distending Toxin of Haemophilus ducreyi Induces Apoptotic Death of Jurkat T Cells , 1999, Infection and Immunity.

[4]  P. Ward,et al.  Campylobacter upsaliensis gastroenteritis in childhood. , 1999, The Pediatric infectious disease journal.

[5]  B. Shenker,et al.  Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. , 1999, Journal of immunology.

[6]  R. Meinersmann,et al.  Apoptotic Effect of Outer-Membrane Proteins from Campylobacter jejuni on Chicken Lymphocytes , 1999, Current Microbiology.

[7]  É. Oswald,et al.  The Cell Cycle-Specific Growth-Inhibitory Factor Produced by Actinobacillus actinomycetemcomitansIs a Cytolethal Distending Toxin , 1998, Infection and Immunity.

[8]  G. Jenkin,et al.  Campylobacter upsaliensis-associated diarrhea in human immunodeficiency virus-infected patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  P. Sherman,et al.  Campylobacter upsaliensis: Waiting in the Wings , 1998, Clinical Microbiology Reviews.

[10]  P. Mirabito,et al.  Campylobacter jejuni Cytolethal Distending Toxin Causes a G2-Phase Cell Cycle Block , 1998, Infection and Immunity.

[11]  N. Figura,et al.  Unusual species of campylobacters isolated in the Siena Tuscany area, Italy. , 1998, The new microbiologica.

[12]  É. Oswald,et al.  Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation , 1997, Infection and immunity.

[13]  V. Aragon,et al.  Effect of cytolethal distending toxin on F-actin assembly and cell division in Chinese hamster ovary cells , 1997, Infection and immunity.

[14]  J. Nougayrède,et al.  A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase , 1997, Molecular microbiology.

[15]  A. Lastovica,et al.  Campylobacter 0:41 isolation in Guillain-Barré syndrome , 1997, Archives of disease in childhood.

[16]  R. Munson,et al.  A diffusible cytotoxin of Haemophilus ducreyi. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Mckhann,et al.  Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after campylobacter infection , 1997, Neurology.

[18]  Y. Takeda,et al.  Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae , 1997, Infection and immunity.

[19]  A. Lastovica,et al.  Adherence to lipids and intestinal mucin by a recently recognized human pathogen, Campylobacter upsaliensis , 1996, Infection and immunity.

[20]  E. Pesci,et al.  Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene , 1996, Infection and immunity.

[21]  J. Nougayrède,et al.  Mitotic block and delayed lethality in HeLa epithelial cells exposed to Escherichia coli BM2-1 producing cytotoxic necrotizing factor type 1 , 1996, Infection and Immunity.

[22]  A. Faruque,et al.  Controlled study of cytolethal distending toxin-producing Escherichia coli infections in Bangladeshi children , 1996, Journal of clinical microbiology.

[23]  V. Chan,et al.  Characterization of Campylobacter upsaliensis fur and its localization in a highly conserved region of the Campylobacter genome. , 1996, Gene.

[24]  N. Cimolai,et al.  Hemolytic-uremic syndrome associated with acute Campylobacter upsaliensis gastroenteritis. , 1996, Nephron.

[25]  T. Nishihara,et al.  Evidence for apoptosis of murine macrophages by Actinobacillus actinomycetemcomitans infection , 1995, Infection and immunity.

[26]  P. Sherman,et al.  Physical and genetic map of the genome of Campylobacter upsaliensis. , 1995, Microbiology.

[27]  Y. Takeda,et al.  Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. , 1995, Microbial pathogenesis.

[28]  B. Kaijser,et al.  Campylobacter upsaliensis, C. sputorum sputorum and C. concisus as common causes of diarrhoea in Swedish children. , 1995, Scandinavian journal of infectious diseases.

[29]  J. Kaper,et al.  Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin , 1994, Infection and immunity.

[30]  W. Dunne,et al.  "Campylobacter upsaliensis" sepsis in a boy with acquired hypogammaglobulinemia. , 1990, Diagnostic microbiology and infectious disease.

[31]  T. Barrett,et al.  Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States , 1989, Journal of clinical microbiology.

[32]  H. Lior,et al.  A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. , 1988, Microbial pathogenesis.

[33]  J. Lanser,et al.  DNA relatedness and biochemical features of Campylobacter spp. isolated in central and South Australia , 1985, Journal of clinical microbiology.